SCHEMBL7417580

SCHEMBL7417580

CC(C)(CC(N)=O)CC(=O)N(C1CCNCC1)C1CCC(C#N)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7425515 0.73 SLC6A2 (0.40)
SCHEMBL7017472 0.71 SLC6A4 (0.37) DPP4
SCHEMBL7018597 0.71 SLC6A4 (0.37) DPP4
SCHEMBL7020799 0.69 SLC6A2 (0.36)
SCHEMBL14655544 0.67 DPP4 (0.40) DPP4
SCHEMBL1309394 0.66 SLC6A4 (0.43)
SCHEMBL7533079 0.65
Pivalate SCHEMBL28484105 0.64 GABRP (0.39) DPP4
Hydrochloric Acid SCHEMBL22797839 0.64 SLC6A4 (0.43)
SCHEMBL5987555 0.64 PTGS1 (0.34) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed